Home » Using PAT to Optimize Cell Culture for Monoclonal Antibody Development
Using PAT to Optimize Cell Culture for Monoclonal Antibody Development
Overview:
Ache Stokelman and colleagues on Amgen’s Global Process Science Team outline how they used BioProcessors Corp.’s SimCell platform to improve results.
Author: Ache Stokelman et al., Amgen Inc. and BioProcessors Corp. | File Type: PDF
Find more white papers on Automation Control
More content on this topic:
Get Connected Now!
- Featured White Papers

Print page